Patents by Inventor Peter C. Nelson

Peter C. Nelson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150238541
    Abstract: This invention provides novel stem cell-based methods for treating a number of conditions. These methods employ CD34 stem cells, and have a tremendous advantage in that they do not require myeloablation in the subject being treated. The CD34 stem cells used in the instant methods can be genetically, modified or not, depending on the disorder treated.
    Type: Application
    Filed: May 8, 2015
    Publication date: August 27, 2015
    Inventors: Ralf Huss, Peter C. Nelson, Matthias C. Raggi, Manfred J. Stangl, SR.
  • Publication number: 20150238526
    Abstract: This invention provides novel stem cell-based methods for treating a number of conditions. These methods employ CD34 stem cells, and have a tremendous advantage in that they do not require myeloablation in the subject being treated. The CD34 stem cells used in the instant methods can be genetically, modified or not, depending on the disorder treated.
    Type: Application
    Filed: May 8, 2015
    Publication date: August 27, 2015
    Applicant: APCETH GMBH & CO. KG
    Inventors: Ralf Huss, Peter C. Nelson, Matthias C. Raggi, Manfred J. Stangl
  • Publication number: 20110268714
    Abstract: This invention provides novel stem cell-based methods for treating a number of conditions. These methods employ CD34? stem cells, and have a tremendous advantage in that they do not require myeloablation in the subject being treated. The CD34? stem cells used in the instant methods can be genetically modified or not, depending on the disorder treated.
    Type: Application
    Filed: July 8, 2011
    Publication date: November 3, 2011
    Inventors: Ralf HUSS, Matthias C. Raggi, Manfred J. Stangl, Peter C. Nelson
  • Patent number: 7998472
    Abstract: This invention provides novel stem cell-based methods for treating a number of conditions. These methods employ CD34? stem cells, and have a tremendous advantage in that they do not require myeloablation in the subject being treated. The CD34? stem cells used in the instant methods can be genetically modified or not, depending on the disorder treated.
    Type: Grant
    Filed: May 20, 2008
    Date of Patent: August 16, 2011
    Assignee: Apceth GmbH & Co. KG
    Inventors: Ralf Huss, Matthias C Raggi, Manfred J Stangl, Peter C Nelson
  • Publication number: 20090041735
    Abstract: This invention provides novel stem cell-based methods for treating a number of conditions. These methods employ CD34? stem cells, and have a tremendous advantage in that they do not require myeloablation in the subject being treated. The CD34? stem cells used in the instant methods can be genetically modified or not, depending on the disorder treated.
    Type: Application
    Filed: May 20, 2008
    Publication date: February 12, 2009
    Applicant: Apceth GmbH & Co. KG
    Inventors: Ralf Huss, Matthias C. Raggi, Manfred J. Stangl, Peter C. Nelson
  • Patent number: 5575201
    Abstract: A compactor assembly comprises a ground supported housing having an open top through which waste material is deposited. An auger is rotatable on an axis positioned within the housing for breaking waste material received therein through the open top, and for transporting the waste material therethrough. A drop area is downstream of the receiving chamber of the housing and has a remote open portion. A compactor ram is reciprocal on an axis parallel to the auger axis for transferring waste material through the open portion. A first drive is operably associated with the auger for rotating the auger, and a second drive is operably associated with the compactor ram for causing reciprocation thereof.
    Type: Grant
    Filed: April 25, 1995
    Date of Patent: November 19, 1996
    Assignee: Marathon Equipment Company
    Inventors: Grant H. Fenner, Kent Spiers, Peter C. Nelson
  • Patent number: 4451002
    Abstract: The temperature actuated valve comprises a thermally more sensitive valve stem than the valve housing. The stem expands at a faster rate and causes vapor entering the valve to be gradually vented through an orifice of gradually increasing area as the temperature of the gas increases. It has application as a cryogenic phase separator valve which allows any cryogen vaporized in a cryogen delivery system to be automatically vented from the valve and to allow for an even flow of liquid to the spray nozzles and onto products of cryogenic freezing tunnels.
    Type: Grant
    Filed: July 19, 1983
    Date of Patent: May 29, 1984
    Assignee: Air Products and Chemicals, Inc.
    Inventors: David J. Klee, Peter C. Nelson
  • Patent number: 4441327
    Abstract: The temperature actuated valve comprises a thermally more sensitive valve stem than the valve housing. The stem expands at a faster rate and causes vapor entering the valve to be gradually vented through an orifice of gradually increasing area as the temperature of the gas increases. It has application as a cryogenic phase separator valve which allows any cryogen vaporized in a cryogen delivery system to be automatically vented from the valve and to allow for an even flow of liquid to the spray nozzles and onto products of cryogenic freezing tunnels.
    Type: Grant
    Filed: December 7, 1981
    Date of Patent: April 10, 1984
    Assignee: Air Products and Chemicals, Inc.
    Inventors: David J. Klee, Peter C. Nelson